Redeye is encouraged by FluoGuide announcing a non-exclusive collaboration with global medtech company Olympus. The agreement aims to explore FG001’s use as an imaging agent and surgical probe in head and neck cancer with Olympus’ technology platforms. While terms of the agreement remain undisclosed, we suspect they are similar to FluoGuide’s collaboration with Intuitive Surgical. This collaboration also lacks an upfront payment, aligning with our expectations. Still, we are encouraged by FluoGuide delivering on its target of inking additional collaboration agreements. We suspect FluoGuide will post additional collaborations in coming years, though their timing is hard to predict. As today’s news aligns with what we expected, we leave our estimates unchanged.
LÄS MER
